Antineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsDoxorubicinDisease-Free SurvivalCyclophosphamideCombined Modality TherapyPrognosisOsteosarcomaCisplatinTreatment OutcomeVincristineChemotherapy, AdjuvantPrecursor Cell Lymphoblastic Leukemia-LymphomaRetrospective StudiesSurvival AnalysisSurvival RateNeoplasm StagingBreast NeoplasmsClinical ProtocolsTumor Markers, BiologicalLung NeoplasmsAntibiotics, AntineoplasticEtoposideFollow-Up StudiesAntineoplastic Agents, PhytogenicNeoplasmsNeoadjuvant TherapyTime FactorsNeoplasm Recurrence, LocalKaplan-Meier EstimateMethotrexateAntineoplastic Agents, AlkylatingDrug Administration ScheduleAntimetabolites, AntineoplasticPaclitaxelMultivariate AnalysisPredictive Value of TestsProspective StudiesDrug Resistance, NeoplasmAdenocarcinomaProportional Hazards ModelsCell Line, TumorImmunohistochemistryNeoplasm MetastasisLymphatic MetastasisBleomycinVinblastineCarboplatinOvarian NeoplasmsCarcinoma, Non-Small-Cell LungCytarabineTaxoidsColorectal NeoplasmsIfosfamideOrganoplatinum CompoundsDisease ProgressionDeoxycytidineBrain NeoplasmsInduction ChemotherapyDose-Response Relationship, DrugCarcinoma, Squamous CellApoptosisAnthracyclinesDrug Screening Assays, AntitumorClinical Trials as TopicRisk FactorsLymphoma, Non-HodgkinCarcinomaGene Expression Regulation, NeoplasticRecurrenceLiver NeoplasmsDaunorubicinCarmustineBone NeoplasmsSalvage TherapyHodgkin DiseaseRadiotherapy, AdjuvantTumor Cells, CulturedRadiotherapyStomach NeoplasmsLomustineCamptothecinTransplantation, AutologousVomitingLeukemia, Myeloid, AcuteNauseaDacarbazineCohort StudiesTesticular NeoplasmsMitomycinMelphalanNeutropeniaChemotherapy, Cancer, Regional PerfusionDrug SynergismCell SurvivalRandomized Controlled Trials as TopicNeoplasm InvasivenessColonic NeoplasmsKi-67 AntigenLymphoma